CAS Number151096-09-2
SynonymsMAXIOFFOXACIN; BAY 12-8039; Moxifloxacin; Moxeza; Avdox; Vigamox; Avelox; Avalox; MFCD04117996
Molecular FormulaC21H24FN3O4
Molecular Weight401.43
Density1.4±0.1 g/cm3
Boiling Point636.4±55.0 °C at 760 mmHg
Melting Point193-195 °C(lit.)
AppearanceAlmost white crystal powder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 151096-09-2 |
| Catalog No. | 2A-9059655 |
| Chinese Name | 莫西沙星 |
| Synonyms | MAXIOFFOXACIN; BAY 12-8039; Moxifloxacin; Moxeza; Avdox; Vigamox; Avelox; Avalox; MFCD04117996 |
| Molecular Formula | C21H24FN3O4 |
| Molecular Weight | 401.43 |
| Density | 1.4±0.1 g/cm3 |
| Boiling Point | 636.4±55.0 °C at 760 mmHg |
| Melting Point | 193-195 °C(lit.) |
| Appearance | Almost white crystal powder |
| Storage Condition | room temperature, dry |
| Application | Moxifloxacin is a synthetic fluoroquinolone antibiotic. |
| HTC | 29329970 |
| SMILES | Fc1cc2c(c(c1N4C[C@H]5[N+H2]CCC[C@H]5C4)OC)N(C=C(C2=O)C(=O)[O-])C3CC3 |
| InChI | 1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1 |
| InChI Key | FABPRXSRWADJSP-MEDUHNTESA-N |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| MSDS | msds/59655_1_151096_09_2.pdf |
| Use of | Properties Name moxifloxacin Synonym More Synonyms Moxifloxacin Biological Activity Related Catalog Signaling Pathways >> Anti-infection >> Bacterial Natural Products >> Alkaloid Research Areas >> Infection References [1]. Balfour, J.A. and H.M. Lamb, Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs, 2000. 59(1): p. 115-39. [2]. Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58(5): p. 379-88. [3]. Ioannidis, O., et al., Effect of moxifloxacin on the survival, lipid peroxidation and inflammation of immunosuppressed rats with soft tissue infection from Stenotrophomonas maltophilia. Microbiol Immunol, 2013. Chemical & Physical Properties Molecular Formula C21H24FN3O4 PSA 83.80000 Index of Refraction 1.633 InChIKey FABPRXSRWADJSP-MEDUHNTESA-N Safety Information Hazard Codes Xn: Harmful; Risk Phrases R22 WGK Germany 3 HS Code 29329970 Synthetic Route 1-Cyclopropyl-6... CAS#:112811-72-0 (S,S)-2,8-Diaza... CAS#:151213-40-0 Moxifloxacin CAS#:151096-09-2 Literature: SANDOZ AG Patent: EP1992626 A1, 2008 ; Location in patent: Page/Page column 10 ; Moxifloxacin HCl CAS#:186826-86-8 Moxifloxacin CAS#:151096-09-2 CAS#:1028205-69-7 Moxifloxacin CAS#:151096-09-2 Precursor & DownStream Precursor 5 CAS#:112811-72-0 1-Cyclopropyl-6... CAS#:151213-40-0 (S,S)-2,8-Diaza... CAS#:186826-86-8 Moxifloxacin HCl CAS#:1028205-71-1 (4aS,7aS)-tert-... DownStream 1 CAS#:186826-86-8 Moxifloxacin HCl |
| Transport Info | Product Name: Moxifloxacin |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| trityl olmesartan | 761404-85-7 | 2A-9059599 |
| Ziprasidone | 146939-27-7 | 2A-9059615 |
| Pemetrexed disodium | 15039-23-8 | 2A-9059634 |
| Codeine | 76-57-3 | 2A-9059636 |
| Erlotinib hydrochloride | 183319-69-9 | 2A-9059637 |
| Acyclovir, Monophosphate | 66341-16-0 | 2A-9059678 |
| Pramipexole | 191217-81-9 | 2A-9059709 |
| Amikacin sulfate salt | 149022-22-0 | 2A-9059760 |
| 6ALPHA-HYDROXYESTRADIOL | 1229-24-9 | 2A-9059890 |
| Capecitabine intermediate | 161599-46-8 | 2A-9059921 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS